2024
DOI: 10.1002/art.42827
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary Damage Biomarkers for Risk of Rheumatoid Arthritis–Associated Interstitial Lung Disease: Enabling Early Detection and Risk Stratification

Pierre‐Antoine Juge,
Paul F. Dellaripa,
Jeffrey A. Sparks

Abstract: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) has garnered increasing attention because of reports of higher-than-expected prevalence with persistent excess mortality, despite the availability of antifibrotics as novel therapeutic options. [1][2][3][4] Although antifibrotics have only modest efficacy, emerging therapeutic options have bolstered efforts for risk stratification, early detection, and identifying risk factors for progression of RA-ILD. Chest high-resolution computed tomography… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 16 publications
(35 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?